Can eGFR be a prognostic factor for endovascular therapy for acute ischemic stroke?

Author:

ERCAN ZaferORCID,BONCUK ULAŞ SenaORCID,ACAR Bilgehan AtılganORCID,ACAR Türkan,DHEIR HamadORCID,GÜZEY ARAS YeşimORCID,İSLAM Mahmud,ERYILMAZ AlperORCID,DALKILIÇ ŞuleORCID,POLAT ZAFER AyşeORCID,UÇAROĞLU CAN NimetORCID

Abstract

Background & Objective: Chronic kidney disease (CKD) is associated with increased mortality risk in acute stroke patients. This study aims to investigate potential association between CKD and the prognosis of endovascular treated acute ischemic stroke patients. Methods: Patients with endovascular treatment (EVT) for acute ischemic stroke were studied retrospectively in a comprehensive stroke center. Patients were classified as pre-procedural CKD and non-CKD. The groups were compared regarding demographic data, procedural data, and outcomes. Results: A total of 140 patients (69 male, 49.3%) with a mean age of 66.51±11.8 were involved in the study. Symptomatic intracranial hemorrhage in the first 24 hours and mortality in three months were increased in the CKD group (50% vs. 19.8; p=0.001). Excellent and good outcomes were decreased in the CKD group (25% vs. 53.4; p=0.01 and 41.6% vs. 56.9%; p=0.03). Multiple logistic regression adjusted for potential confounders demonstrated that CKD was associated with lower rates of excellent outcome (odds ratio [OR] = 0.50, 95% confidence interval [CI], 0.25 to 0.80, p = 0.01), higher mRS scores (common OR = 1.82, 95% CI, 1.2 to 2.9, p = 0.01), and increased mortality (OR = 2.1, 95% CI, 1.2 to 4.2, p = 0.01) and sICH (OR = 1.15, 95% CI, 1.03 to 3.4, P = 0.04) Conclusion: There is an association between CKD and poorer results in patients with acute ischemic stroke treated with EVT. The presence of CKD should not prohibit patients from undergoing EVT, but taking baseline eGFR into account may improve estimation of prognosis and help decision-making in treatment modality.

Publisher

ASEAN Neurological Association

Subject

Neurology (clinical),Neurology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3